Back to Screener

US Physical Therapy Inc (USPH)

Price$63.45
Value ScoreC
Growth ScoreC
Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (26W)-22.01%
Price vs S&P 500 (4W)7.03%
VGM Score45.56
Market Capitalization$941.59M
P/E Ratio (Annual)23.79x
Indicated Dividend Yield (Annual)3.06%

All Metrics

P/CF (Annual)12.54x
Book Value / Share (Quarterly)$30.79
P/TBV (Annual)3.91x
Indicated Dividend (Annual)$1.84
Revenue Growth (3Y)12.19%
Cash Flow / Share (Quarterly)$4.38
Payout Ratio (TTM)92.18%
Price vs S&P 500 (YTD)-26.91%
Gross Margin (TTM)19.02%
Net Profit Margin (TTM)4.36%
EPS (TTM)$2.29
10-Day Avg Trading Volume0.18M
EPS Excl Extra (TTM)$2.29
Revenue Growth (5Y)13.05%
EPS (Annual)$2.61
Dividend / Share (Annual)$1.81
ROI (Annual)6.20%
Gross Margin (Annual)19.20%
Net Profit Margin (5Y Avg)5.70%
Cash / Share (Quarterly)$1.87
P/E Basic Excl Extra (TTM)27.12x
Revenue Growth QoQ (YoY)7.89%
EPS Growth (5Y)-1.05%
P/E Normalized (Annual)23.79x
ROA (Last FY)3.29%
Revenue Growth TTM (YoY)13.73%
EBITD / Share (TTM)$6.72
ROE (5Y Avg)8.93%
Operating Margin (TTM)10.00%
Cash Flow / Share (Annual)$4.03
P/B Ratio2.01x
P/B Ratio (Quarterly)2.42x
Net Income / Employee (Annual)$9,400
EV / Revenue (TTM)1.41x
Net Interest Coverage (TTM)11.49x
ROA (TTM)2.88%
EPS Growth QoQ (YoY)-49.22%
EV / EBITDA (TTM)10.96x
EPS Incl Extra (Annual)$2.61
Current Ratio (Annual)1.01x
Quick Ratio (Quarterly)1.19x
3-Month Avg Trading Volume0.20M
52-Week Price Return-16.29%
EV / Free Cash Flow (Annual)18.33x
P/E Incl Extra (TTM)27.12x
Revenue / Employee (TTM)$189,400
Tangible BV / Share (Quarterly)$18.99
P/S Ratio (Annual)1.21x
Asset Turnover (Annual)0.65x
52-Week High$93.50
Operating Margin (5Y Avg)10.82%
EPS Excl Extra (Annual)$2.61
CapEx CAGR (5Y)12.99%
Tangible BV CAGR (5Y)6.66%
26-Week Price Return-14.08%
Quick Ratio (Annual)1.01x
13-Week Price Return-23.21%
Total Debt / Equity (Annual)0.34x
Current Ratio (Quarterly)1.19x
Enterprise Value$1.12B
Revenue / Share Growth (5Y)9.26%
Asset Turnover (TTM)0.66x
Book Value / Share Growth (5Y)8.03%
Revenue / Employee (Annual)$186,000
Pretax Margin (Annual)9.96%
Cash / Share (Annual)$2.35
3-Month Return Std Dev49.54%
Gross Margin (5Y Avg)20.47%
Net Income / Employee (TTM)$8,300
EBITDA CAGR (5Y)7.35%
EBITDA Interim CAGR (5Y)0.89%
ROE (Last FY)8.31%
Net Interest Coverage (Annual)9.98x
EPS Basic Excl Extra (Annual)$2.61
P/FCF (TTM)13.80x
Receivables Turnover (TTM)8.48x
EV / Free Cash Flow (TTM)16.77x
Total Debt / Equity (Quarterly)0.44x
EPS Incl Extra (TTM)$2.29
Receivables Turnover (Annual)8.98x
ROI (TTM)5.27%
Dividend Growth Rate (5Y)41.45%
P/S Ratio (TTM)1.18x
Pretax Margin (5Y Avg)10.39%
Revenue / Share (Annual)$51.47
Tangible BV / Share (Annual)$20.07
Forward P/E20.92x
Free OCF CAGR (5Y)-7.97%
Price vs S&P 500 (52W)-40.66%
P/E Ratio (TTM)27.12x
EPS Growth TTM (YoY)3.68%
Year-to-Date Return-18.75%
5-Day Price Return1.47%
EPS Normalized (Annual)$2.61
ROA (5Y Avg)3.60%
Net Profit Margin (Annual)5.07%
Month-to-Date Return-1.26%
Cash Flow / Share (TTM)$4.18
EBITD / Share (Annual)$7.18
EPS Growth (3Y)1.74%
Operating Margin (Annual)11.08%
LT Debt / Equity (Annual)0.32x
P/CF (TTM)11.27x
ROI (5Y Avg)6.39%
P/E Excl Extra (TTM)27.12x
LT Debt / Equity (Quarterly)0.41x
EPS Basic Excl Extra (TTM)$2.29
P/TBV (Quarterly)3.92x
Payout Ratio (Annual)69.13%
P/B Ratio (Annual)2.49x
Dividend / Share (TTM)$1.81
Pretax Margin (TTM)8.93%
Book Value / Share (Annual)$31.50
Price vs S&P 500 (13W)-31.47%
Net Margin Growth (5Y)-9.43%
Dividend Yield (TTM)2.91%
Beta1.15x
P/FCF (Annual)15.44x
Revenue / Share (TTM)$52.45
ROE (TTM)7.12%
52-Week Low$58.19
vGradeC
gGradeC
mGradeD
vgmGradeC
Show chart for

Earnings Surprise History

Q1 260.46est. 0.56

Analyst Recommendations

Feb 2026
Mar 2026
Apr 2026
May 2026
4.23
4.23
4.23
4.23

About

US Physical Therapy operates outpatient clinics specializing in orthopedic, sports medicine, post-operative, and neurological rehabilitation services. Revenue is derived from managed care, commercial insurance, Medicare, Medicaid, workers' compensation, and personal injury claims, with the physical therapy operations segment generating the majority of revenue.